PerkinElmer, Inc. is a global technology company which provides products and systems to the telecom, medical, pharmaceutical, chemical, semiconductor and photographic markets. The Company has operations in over 100 countries, and is a component of the S&P 500 Index. The Company's continuing operations are classified into four operating segments:Life Sciences, Optoelectronics, Instruments, and Fluid Sciences.
940 WINTER STREET WALTHAM, MA 02451, USA Phone: 7816635776 Fax: 781-663-5985 Web: http://www.perkinelmer.com
Industry:INSTRU-SCIENTFC Sector: Computer and Technology Fiscal Year End:December Last Reported Quarter:12/31/11 Next EPS Date:05/10/12
Capital Structure Solvency and Cash Flow
Operating cash flow from continuing operation was $64.2 million in 4Q09 versus $93.4 million in 4Q08, due to the timing of payments for restructuring and compensation expenses. In FY09, adjusted operating cash flow from continuing operations was $198.3 million versus $214.5 million in FY08. The firm generated Free Cash Flow $53 in 4Q09 versus $28 million in 4Q08.
Dividend: On January 25, 2010, PKI declared a regular quarterly dividend of $0.07 per share of common stock on January 24, 2010. This dividend is payable on May 7, 2010, to all shareholders of record at the close of business on April 16, 2010.
Last edited Wed Mar 10, 2010 11:32 PM by SudiptaMukherjee (Zacks Investment Research)
6
Governance Social Responsibility and Employee Relations
PKI acquired two small businesses in 3Q09, SYM-BIO LifeScience, which strengthened its manufacturing capability in China, providing access to infectious disease diagnostic products, and Surendra Genetic Labs in India. In addition to expanding its presence in the high growth emerging markets, the company strengthened its research division by acquiring GE’s radiochemical research portfolio, which is used in drug development.
Last edited Wed Mar 10, 2010 11:32 PM by SudiptaMukherjee (Zacks Investment Research)
Recent and Upcoming Events
Major Risks
Technological Change: PKI operates in sectors that are characterized by rapid technological change and evolving industry standards. Success in these areas will require heavy investments in R&D to maintain a competitive pipeline.
International Exposure: With a major portion of its revenue coming from outside the US, the company is exposed to foreign currency exchange risk, political risk, and foreign regulatory issues among others.
Integration Risk: A large part of the company’s growth is contingent upon acquisitions. If PKI fails to retain key employees or integrate acquisitions successfully, its results would be materially affected.
Last edited Wed Mar 10, 2010 11:33 PM by SudiptaMukherjee (Zacks Investment Research)
Created by: WikiMigrationBot.
Last Modification: Thursday 03 of June, 2010 08:34:22 CDT by WikiMigrationBot.
